Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03778827 · ClinicalTrials.gov registry record · NA

A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism

A NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.

Active
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT03778827: Active NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.

NCT03778827 is a NA study of Autism Spectrum Disorder and Autism that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 75 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03778827, a NA study of Autism Spectrum Disorder and Autism, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the effectiveness of pivotal response training (PRT) in an intensive center-based environment to treat social communication deficits in children with autism spectrum disorder (ASD).

Interventions

  • BEHAVIORAL Intensive Center-Based Pivotal Response Treatment (PRT-C)

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2019-05-13
Est. Completion 2026-06
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03778827

The ClinicalTrials.gov registry entry for NCT03778827 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (44% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Intensive Center-Based Pivotal Response Treatment (PRT-C) is the first listed.

NCT03778827 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03778827 about?

NCT03778827 is a clinical study titled "A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism". The purpose of this study is to examine the effectiveness of pivotal response training (PRT) in an intensive center-based environment to treat social communication deficits in children with autism spectrum disorder (ASD).

What is the current status of trial NCT03778827?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2019-05-13. Estimated completion is 2026-06.

What conditions does trial NCT03778827 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism.

What interventions are being tested in trial NCT03778827?

The interventions under investigation include: Intensive Center-Based Pivotal Response Treatment (PRT-C) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03778827?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03778827 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.